Beyond membranes: the multifaceted mechanisms of antimicrobial peptides

Antimicrobial peptides are emerging as critical alternatives to conventional antibiotics, particularly in the fight against multidrug-resistant pathogens, including Mycobacterium tuberculosis and Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp . While antimicrobial peptides are traditionally known for their membrane-disruptive properties, increasing evidence reveals a broader spectrum of intracellular and molecular actions that remain underexplored. This review aims to systematically examine the alternative mechanisms of antimicrobial peptides that extend beyond membrane disruption. The review then explores non-classical antimicrobial peptide activities, including cellular penetration and subcellular localization, interference with essential metabolic pathways (e.g., mycolic acid and protein synthesis), modulation of host cell signaling (autophagy, inflammation), and inhibition of bacterial virulence and persistence mechanisms. Case studies of specific antimicrobial peptides that act through these alternative pathways are presented, along with comparisons to traditional agents. Finally, we discuss the clinical potential of antimicrobial peptides, the pharmacokinetic and immunological challenges in their development, and current strategies to enhance intracellular efficacy and selectivity. Understanding the non-canonical mechanisms of antimicrobial peptides opens new avenues for antimicrobial therapy, particularly against intracellular and drug-resistant pathogens. This review underscores the need for deeper mechanistic studies and innovative drug design approaches to fully exploit the therapeutic potential of antimicrobial peptides beyond membrane disruption.

Authors

Institutions

Publication Details

Journal
Frontiers in Drug Discovery
Published
2026-11-16
DOI
https://doi.org/10.3389/fddsv.2026.1918811
Primary Topic
Antimicrobial Peptides and Activities
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Beyond membranes: the multifaceted mechanisms of antimicrobial peptides

Roxana Yesenia Pastrana Alta, Fernando Rogerio Pavan, Christian Shleider Carnero Canales, Ana Carolina Cerqueira Negri et al.
2 links
Frontiers in Drug Discovery
Antimicrobial Peptides and Activities
article

Beyond membranes: the multifaceted mechanisms of antimicrobial peptides

Roxana Yesenia Pastrana Alta, Fernando Rogerio Pavan, Christian Shleider Carnero Canales, Ana Carolina Cerqueira Negri, Edson Reinaldo, Carlos Arturo Rebaza-Chavez, Ana Clara Brunelli, Fatimah Nery Jacinto, Vinicius Oliveira Chesna, Janaína Teixeira Costa de Pontes
article en

Abstract

Antimicrobial peptides are emerging as critical alternatives to conventional antibiotics, particularly in the fight against multidrug-resistant pathogens, including Mycobacterium tuberculosis and Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp . While antimicrobial peptides are traditionally known for their membrane-disruptive properties, increasing evidence reveals a broader spectrum of intracellular and molecular actions that remain underexplored. This review aims to systematically examine the alternative mechanisms of antimicrobial peptides that extend beyond membrane disruption. The review then explores non-classical antimicrobial peptide activities, including cellular penetration and subcellular localization, interference with essential metabolic pathways (e.g., mycolic acid and protein synthesis), modulation of host cell signaling (autophagy, inflammation), and inhibition of bacterial virulence and persistence mechanisms. Case studies of specific antimicrobial peptides that act through these alternative pathways are presented, along with comparisons to traditional agents. Finally, we discuss the clinical potential of antimicrobial peptides, the pharmacokinetic and immunological challenges in their development, and current strategies to enhance intracellular efficacy and selectivity. Understanding the non-canonical mechanisms of antimicrobial peptides opens new avenues for antimicrobial therapy, particularly against intracellular and drug-resistant pathogens. This review underscores the need for deeper mechanistic studies and innovative drug design approaches to fully exploit the therapeutic potential of antimicrobial peptides beyond membrane disruption.

Frontiers in Drug DiscoveryVol. 6
National University of Trujillo (PE), Centro Universitário de Araraquara (BR), National University of Engineering (PE), Universidade Estadual Paulista (Unesp) (BR)
Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica
Good health and well-being
Antimicrobial Peptides and Activities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon